Physical exercise, fasting glucose, and renal hyperfiltration in the general population: The renal iohexol clearance survey in Tromsø 6 (RENIS-T6)

Clinical Journal of the American Society of Nephrology

Volumn 7, Issue 11, 2012, Pages 1801-1810

  Melsom, Toralf ^a   Mathisen, Ulla Dorte ^a   Eilertsen, Britt Ann Winther ^a   Ingebretsen, Ole C ^b   Jenssen, Trond ^a,b   Njølstad, Inger ^c   Solbu, Marit D ^a   Toft, Ingrid ^a   Eriksen, Bjørn O ^a  

^a UNIVERSITY HOSPITAL OF NORTH NORWAY   (Norway)

^b UNIVERSITY OF TROMSØ   (Norway)

^c OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; IOHEXOL;

ADULT; ARTICLE; DIET RESTRICTION; EXERCISE; FEMALE; GLOMERULUS FILTRATION; GLOMERULUS FILTRATION RATE; HUMAN; HUMAN EXPERIMENT; LEISURE; MALE; PLASMA CLEARANCE; QUESTIONNAIRE; RISK REDUCTION; SEX DIFFERENCE;

BLOOD GLUCOSE; EXERCISE; FASTING; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; IOHEXOL; MALE; METABOLIC CLEARANCE RATE; MIDDLE AGED;

EID: 84869133354     PISSN: 15559041     EISSN: 1555905X     Source Type: Journal    
DOI: 10.2215/CJN.02980312     Document Type: Article

References (50)

1. Tsukamoto Y, Wang H, Becker G, Chen HC, Han DS, Harris D, Imai E, Jha V, Li PK, Lee EJ, Matsuo S, Tomino Y, Tungsanga K, Yamagata K, Hishida A: Report of the Asian Forum of Chronic Kidney Disease Initiative (AFCKDI) 2007. "Current status and perspective of CKD in Asia": Diversity and specificity among Asian countries. Clin Exp Nephrol 13: 249-256, 2009
2. Stengel B, Tarver-Carr ME, Powe NR, Eberhardt MS, Brancati FL: Lifestyle factors, obesity and the risk of chronic kidney disease. Epidemiology 14: 479-487, 2003
3. Solbu MD, Kronborg J, Eriksen BO, Jenssen TG, Toft I: Cardiovascular risk-factors predict progression of urinary albuminexcretion in a general, non-diabetic population:A gender-specific follow-up study. Atherosclerosis 201: 398-406, 2008
4. Robinson-Cohen C, Katz R, Mozaffarian D, Dalrymple LS, de Boer I, Sarnak M, Shlipak M, Siscovick D, Kestenbaum B: Physical activity and rapid decline in kidney function among older adults. Arch Intern Med 169: 2116-2123, 2009
5. Hallan S, de Mutsert R, Carlsen S, Dekker FW, Aasarød K, Holmen J: Obesity, smoking, and physical inactivity as risk factors for CKD: Are men more vulnerable? Am J Kidney Dis 47: 396-405, 2006
6. Brenner BM, Lawler EV, Mackenzie HS: The hyperfiltration theory: A paradigm shift in nephrology. Kidney Int 49: 1774-1777, 1996
7. Magee GM, Bilous RW, Cardwell CR, Hunter SJ, Kee F, Fogarty DG: Is hyperfiltration associated with the future risk of developing diabetic nephropathy? A meta-analysis. Diabetologia 52: 691-697, 2009
8. Wuerzner G, Pruijm M, Maillard M, Bovet P, Renaud C, Burnier M, Bochud M: Marked association between obesity and glomerular hyperfiltration: A cross-sectional study in an African population. Am J Kidney Dis 56: 303-312, 2010
9. Cherney DZ, Miller JA, Scholey JW, Nasrallah R, Hébert RL, Dekker MG, Slorach C, Sochett EB, Bradley TJ: Renal hyperfiltration is a determinant of endothelial function responses to cyclooxygenase 2 inhibition in type 1 diabetes. Diabetes Care 33: 1344-1346, 2010
10. Melsom T, Mathisen UD, Ingebretsen OC, Jenssen TG, Njølstad I, Solbu MD, Toft I, Eriksen BO: Impaired fasting glucose is associated with renal hyperfiltration in the general population. Diabetes Care 34: 1546-1551, 2011
11. Cowie CC, Rust KF, Ford ES, Eberhardt MS, Byrd-Holt DD, Li C, Williams DE, Gregg EW, Bainbridge KE, Saydah SH, Geiss LS: Full accounting of diabetes and pre-diabetes in the U.S. population in 1988-1994 and 2005-2006. Diabetes Care 32: 287-294, 2009
12. Ribeiro F, Alves AJ, Duarte JA, Oliveira J: Is exercise training an effective therapy targeting endothelial dysfunction and vascular wall inflammation? Int J Cardiol 141: 214-221, 2010
13. Meredith IT, Friberg P, Jennings GL, Dewar EM, Fazio VA, Lambert GW, Esler MD: Exercise training lowers resting renal but not cardiac sympathetic activity in humans. Hypertension 18: 575-582, 1991
14. Stevens LA, Levey AS: Measured GFR as a confirmatory test for estimated GFR. J Am Soc Nephrol 20: 2305-2313, 2009
15. Jacobsen BK, Eggen AE, Mathiesen EB, Wilsgaard T, Njolstad I: Cohort profile: The Tromso Study [published online ahead of print April 21, 2011]. Int J Epidemioldoi: 10.1093/ije/dyr049
16. International Expert Committee: International Expert Committee report on the role of the A1C assay in the diagnosis of diabetes. Diabetes Care 32: 1327-1334, 2009
17. Levey AS, Coresh J, Balk E, Kausz AT, Levin A, Steffes MW, Hogg RJ, Perrone RD, Lau J, Eknoyan G; National Kidney Foundation: National Kidney Foundation practice guidelines for chronic kidney disease: Evaluation, classification, and stratification. Ann Intern Med 139: 137-147, 2003
18. Kurtze N, Rangul V, Hustvedt BE, Flanders WD: Reliability and validity of self-reported physical activity in the Nord-Trøndelag Health Study: HUNT 1. Scand J Public Health 36: 52-61, 2008
19. Jacobsson L: A method for the calculation of renal clearance based on a single plasma sample. Clin Physiol 3: 297-305, 1983
20. Nilsson-Ehle P: Iohexol clearance for the determination of glomerular filtration rate: 15 yearś experience in clinical practice. E J Int Fed Clin Chem Lab Med 13, 2006
21. Eriksen BO, Mathisen UD, Melsom T, Ingebretsen OC, Jenssen TG, Njølstad I, Solbu MD, Toft I: Cystatin C is not a better estimator of GFR than plasma creatinine in the general population. Kidney Int 78: 1305-1311, 2010
22. Levey AS, Coresh J, Greene T, Stevens LA, Zhang YL, Hendriksen S, Kusek JW, Van Lente F; Chronic Kidney Disease Epidemiology Collaboration: Using standardized serumcreatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate. Ann Intern Med 145: 247-254, 2006
23. Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF 3rd, Feldman HI, Kusek JW, Eggers P, Van Lente F, Greene T, Coresh J; CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration): A new equation to estimate glomerular filtration rate. Ann Intern Med 150: 604-612, 2009
24. Rule AD, Bergstralh EJ, Slezak JM, Bergert J, Larson TS: Glomerular filtration rate estimated by cystatin C among different clinical presentations. Kidney Int 69: 399-405, 2006
25. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC: Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28: 412-419, 1985
26. Kikuya M, Hansen TW, Thijs L, Björklund-Bodega°rd K, Kuznetsova T, Ohkubo T, Richart T, Torp-Pedersen C, Lind L, Ibsen H, Imai Y, Staessen JA; International Database on Ambulatory blood pressure monitoring in relation to Cardiovascular Outcomes Investigators: Diagnostic thresholds for ambulatory blood pressure monitoring based on 10-year cardiovascular risk. Circulation 115: 2145-2152, 2007
27. Finkelstein J, Joshi A, Hise MK: Association of physical activity and renal function in subjects with andwithoutmetabolic syndrome: A review of the Third National Health and Nutrition Examination Survey (NHANES III). Am J Kidney Dis 48: 372-382, 2006
28. Mathisen UD, Melsom T, Ingebretsen OC, Jenssen T, Njølstad I, Solbu MD, Toft I, Eriksen BO: Estimated GFR associates with cardiovascular risk factors independently ofmeasuredGFR. J Am Soc Nephrol 22: 927-937, 2011
29. Cherney DZ, Sochett EB, Dekker MG, Perkins BA: Ability of cystatin C to detect acute changes in glomerular filtration rate provoked by hyperglycaemia in uncomplicated Type 1 diabetes. Diabet Med 27: 1358-1365, 2010
30. Balducci S, Zanuso S, Nicolucci A, Fernando F, Cavallo S, Cardelli P, Fallucca S, Alessi E, Letizia C, Jimenez A, Fallucca F, Pugliese G: Anti-inflammatory effect of exercise training in subjects with type 2 diabetes and the metabolic syndrome is dependent on exercise modalities and independent of weight loss. Nutr Metab Cardiovasc Dis 20: 608-617, 2010
31. Krop JS, Coresh J, Chambless LE, Shahar E, Watson RL, Szklo M, Brancati FL: A community-based study of explanatory factors for the excess risk for early renal function decline in blacks vs whites with diabetes: the Atherosclerosis Risk in Communities study. Arch Intern Med 159: 1777-1783, 1999
32. White SL, Dunstan DW, Polkinghorne KR, Atkins RC, Cass A, Chadban SJ: Physical inactivity and chronic kidney disease in Australian adults: The Aus Diab study. Nutr Metab Cardiovasc Dis 21: 104-112, 2011
33. Palatini P, Mormino P, Dorigatti F, Santonastaso M, Mos L, De Toni R, Winnicki M, Dal Follo M, Biasion T, Garavelli G, Pessina AC; HARVEST Study Group: Glomerular hyperfiltration predicts the development of microalbuminuria in stage 1 hypertension: the HARVEST. Kidney Int 70: 578-584, 2006
34. Lee I, Blair SN, Manson J, Paffenbarger RSJ: Epidemiologic Methods in Physical Activity Studies, New York, NY, Oxford University Press, 2009
35. Emaus A, Degerstrøm J, Wilsgaard T, Hansen BH, Dieli-Conwright CM, Furberg AS, Pettersen SA, Andersen LB, Eggen AE, Bernstein L, Thune I: Does a variation in self-reported physical activity reflect variation in objectively measured physical activity, resting heart rate, and physical fitness? Results from the Tromso study. Scand J Public Health 38[Suppl]: 105-118, 2010
36. Verhave JC, Hillege HL, Burgerhof JG, Navis G, de Zeeuw D, de Jong PE; PREVEND Study Group: Cardiovascular risk factors are differently associated with urinary albumin excretion in men and women. J Am Soc Nephrol 14: 1330-1335, 2003
37. Lewko B, Stepinski J: Hyperglycemia and mechanical stress: Targeting the renal podocyte. J Cell Physiol 221: 288-295, 2009
38. Brantsma AH, Atthobari J, Bakker SJ, de Zeeuw D, de Jong PE, Gansevoort RT: What predicts progression and regression of urinary albumin excretion in the nondiabetic population? J Am Soc Nephrol 18: 637-645, 2007
39. Halbesma N, Brantsma AH, Bakker SJ, Jansen DF, Stolk RP, De Zeeuw D, De Jong PE, Gansevoort RT; PREVEND study group: Gender differences in predictors of the decline of renal function in the general population. Kidney Int 74: 505-512, 2008
40. Verhave JC, Hillege HL, Burgerhof JG, Gansevoort RT, de Zeeuw D, de Jong PE; PREVEND Study Group: The association between atherosclerotic risk factors and renal function in the general population. Kidney Int 67: 1967-1973, 2005
41. Hespel P, Lijnen P, Van Hoof R, Fagard R, Goossens W, Lissens W, Moerman E, Amery A: Effects of physical endurance training on the plasma renin-angiotensin-aldosterone systemin normal man. J Endocrinol 116: 443-449, 1988
42. Haskell WL, Lee IM, Pate RR, Powell KE, Blair SN, Franklin BA, Macera CA, Heath GW, Thompson PD, Bauman A; American College of Sports Medicine American Heart Association: Physical activity and public health: Updated recommendation for adults fromthe American College of Sports Medicine and the American Heart Association. Circulation 116: 1081-1093, 2007
43. Tyldum GA, Schjerve IE, Tjønna AE, Kirkeby-Garstad I, Stølen TO, Richardson RS, Wisløff U: Endothelial dysfunction induced by post-prandial lipemia: Complete protection afforded by highintensity aerobic interval exercise. J Am Coll Cardiol 53: 200-206, 2009
44. Herder C, Peltonen M, Koenig W, Sütfels K, Lindström J, Martin S, Ilanne-Parikka P, Eriksson JG, Aunola S, Keinänen-Kiukaanniemi S, Valle TT, Uusitupa M, Kolb H, Tuomilehto J; Finnish Diabetes Prevention Study Group: Anti-inflammatory effect of lifestyle changes in the Finnish Diabetes Prevention Study. Diabetologia 52: 433-442, 2009
45. Forbes JM, Coughlan MT, Cooper ME: Oxidative stress as amajor culprit in kidney disease in diabetes. Diabetes 57: 1446-1454, 2008
46. Pistrosch F, Herbrig K, Kindel B, Passauer J, Fischer S, Gross P: Rosiglitazone improves glomerular hyperfiltration, renal endothelial dysfunction, and microalbuminuria of incipient diabetic nephropathy in patients. Diabetes 54: 2206-2211, 2005
47. Lal MA, Körner A, Matsuo Y, Zelenin S, Cheng SX, Jaremko G, DiBona GF, Eklöf AC, Aperia A: Combined antioxidant and COMT inhibitor treatment reverses renal abnormalities in diabetic rats. Diabetes 49: 1381-1389, 2000
48. Hernández-Marco R, Codõner-Franch P, Pons Morales S, Del Castillo Villaescusa C, Boix Garci{dotless}́a L, Valls Bellés V: Oxidant/ antioxidant status and hyperfiltration in young patients with type 1 diabetes mellitus. Pediatr Nephrol 24: 121-127, 2009
49. Kodera R, Shikata K, Kataoka HU, Takatsuka T, Miyamoto S, Sasaki M, Kajitani N, Nishishita S, Sarai K, Hirota D, Sato C, Ogawa D, Makino H: Glucagon-like peptide-1 receptor agonist ameliorates renal injury through its anti-inflammatory action without lowering blood glucose level in a rat model of type 1 diabetes. Diabetologia 54: 965-978, 2011
50. Persson MF, Franzen S, Catrina S. B, Dallner G, Hansell P, Brismar K, Palm F: Coenzyme Q10 prevents GDP-sensitive mitochondrial uncouplilng, glomerular hyperfiltration and proteinuria in kidneys from db/db mice as a model of type 2 diabetes. Diabetologia 55: 1535-1543, 2012.